Production (Stage)
Restart Life Sciences Corp.
NMLSF
$0.048
$0.011531.51%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -299.70K | 163.70K | 9.60K | -464.50K | -623.70K |
| Total Depreciation and Amortization | 1.50K | 1.60K | 1.70K | 1.80K | 1.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.10K | -422.40K | -421.30K | 0.00 | 0.00 |
| Change in Net Operating Assets | 118.80K | 204.10K | 353.10K | 414.30K | 508.70K |
| Cash from Operations | -182.40K | -52.80K | -56.70K | -48.20K | -112.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 15.00K | 75.00K | 60.00K | 60.00K | 60.00K |
| Total Debt Repaid | -83.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 550.00K | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 336.10K | 55.20K | 44.50K | 44.50K | 44.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 153.60K | 2.40K | -12.20K | -3.70K | -68.40K |